Fifty 1 Labs, Inc. and All-In-Extracts Announce Joint Venture to Develop and Release New Testosterone Boosting Supplement

August 5, 2024

MELBOURNE, Fla., Aug. 5, 2024 /PRNewswire/ — Fifty 1 Labs, Inc. (OTC-PINK: CAFI), a holding company that operates in the sports supplement, fitness equipment, and health and wellness industries, and All-In-Extracts, a wholly owned subsidiary of Royal Biotek Enterprises (OTC-PINK: BLEG) and a renowned provider of high-quality botanical extracts, are excited to announce a strategic joint venture to develop and release a groundbreaking testosterone-boosting supplement under Fifty 1 Labs wholly owned subsidiary, 51 Labs, LLC. Clinical trials for this innovative product are set to begin promptly.

Read more at prnewswire.com

Related news for (CAFI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.